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Abstract: Androgens are especially important for the maintenance of spermatogenesis in adulthood and the experimental
withdrawal of testosterone (T) production by ethane dimenthanesulfonate (EDS) is a valuable tool for studying androgen-de-
pendent events of spermatogenesis. The aim of the present study was to investigate the specific changes in immunoexpression
of androgen receptor (AR) in the testis in relation to degeneration and regeneration of Leydig cell (LC) population and
seminiferous epithelium. Immunohistochemistry for AR and 3β-hydroxysteroid dehydrogenase (3β-HSD) as well as TUNEL
assay for apoptosis were performed on testicular sections of control and EDS-treated rats. Serum LH and T levels were measured
by RIA. Our results revealed a total loss of AR immunoexpression from the nuclei of Sertoli (SCs), LCs and peritubular cells
during the first week after EDS administration and that coincided with severe drop in T levels. Two weeks after EDS
administration, the AR expression was recovered in these cells but normal stage-specificity in SCs was replaced by uniform
intensity of AR immunostaining at all the stages of the spermatogenic cycle. The stage-specific pattern of androgen expression
in SCs with a maximum at stages VII-VIII appeared 5 weeks after treatment. LC immunoreactivity for 3β-HSD at different
time points after EDS administration correlated with values of T concentration. The maximal germ cell apoptosis on day 7 was
followed by total loss of elongated spermatids 2 weeks after EDS treatment. Regeneration of seminiferous epithelium 3 weeks
after EDS administration and onwards occurred in tandem with the development of new LC population indicated by the
appearance of 3β-HSD-positive cells and gradual increase in T production. The specific changes in AR after EDS including
their loss and recovery in Sertoli cells paralleled with degenerative and regenerative events in Leydig and germ cell populations,
confirming close functional relationship between Sertoli, Leydig and germ cells. (www.cm-uj.krakow.pl/FHC)
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Introduction
Androgens are especially important in male sexual dif-
ferentiation in fetal life, pubertal sexual maturation and
the maintenance of spermatogenesis in adulthood. The
effects of androgens are mediated through the androgen
receptor (AR), a 110 kDa nuclear receptor that binds
testosterone (T) with high affinity and regulates gene
expression in the target tissues [12] . Several pieces of
evidence indicated the preferential action of androgens
at stages VII-VIII of the spermatogenic cycle of the rat
[15, 22] and this coincided with the maximal expression
of AR protein in Sertoli cells (SCs) [8]. As immunoex-
prssion of AR in peritubular (PTCs) and Leydig cells
(LCs) does not vary according to the stages of the cycle,
it is presumed that androgen support for spermatogen-
esis is primarily mediated through the Sertoli cells [23].
This conclusion is supported by recent demonstration that
Sertoli cell selective ablation of AR (SCARKO mice)
results in arrest of spermatogenesis during meiosis [10]. 
Experimental manipulation of T levels during devel-
opment [17] and adulthood [8, 25, 27] results in a loss
of AR immunoexpression in the Sertoli cells, suggesting
the specific role of T-ligand for the proper functioning
of its own receptor. Treatment of adult rats with ethane
dimethanesulfonate (EDS) selectively and temporarily
eliminates LCs in the testis resulting in rapid loss of T
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production and hence is a valuable tool for investigating
androgen-dependent events of spermatogenesis [25].
AR protein expression was investigated within the first
6 days after EDS treatment, when dramatic loss of AR
expression in SCs was found, whereas germ cell com-
partment remained still quantitatively normal. Recovery
of the normal stage-specific pattern of AR expression in
the SCs was achieved by immediate therapy with high
dose T within the first 3 days post EDS [25].
AR protein expression has not been examined in a
long-term period after EDS administration when new
population of LCs develops resulting in gradual restora-
tion of their steroidogenic function. In this respect, the
aim of the present study was to investigate the specific
changes in immunoexpression of AR in the testis in relation
to degeneration and regeneration of LC population and
spermatogenesis and to extend our understanding of the
mechanisms via which androgens act in the testis.
Materials and methods
Animals and treatments. Adult Wistar rats bred in our animal house
were maintained under standard conditions. Food and water were
provided ad libitum. Testosterone withdrawal in adult rats was
induced by single intraperitoneal injection of ethanedimethane sul-
phonate (EDS) at a dose of 75 mg/kg body weight dissolved in
dimethylsulfoxide and water (1:3, v/v). EDS is not commercially
available and was synthesized in our laboratory from ethylene glycol
and methane sulfonylchloride as described by Jackson and Jackson
[13]. Control rats were treated with the vehicle alone. Animals were
sacrificed at 1, 3, 7 ,14, 21 and 35 days after EDS. Plasma samples
were stored at -20˚C until used for hormonal analysis of testosterone
and LH by RIA. Testes were fixed in Bouin’s solution, dehydrated
and embedded in paraffin.
Imminohistochemistry. Immunohistochemistry was performed on
dewaxed sections (5 µm) with antigen retrieval (5 min in 0.01 M
citrate buffer, pH 6.0) for visualization of AR or without antigen
retrieval for 3β-HSD. This was followed by endogenous peroxidase
blocking in 3% (v/v) H2O2 in methanol for 30 min at room tempera-
ture (RT). For all washes between antibody or reagent incubations,
0.05 M TBS, pH 7.4, 2×5 min at RT was used. Tissue sections were
blocked in TBS containing normal swine serum (NSS; 1:4) and 5%
BSA before an overnight incubation at 4˚C with primary antibodies
diluted in NSS. For detection of AR and Leydig cells, rabbit poly-
clonal antibodies, clone N20, sc-816, Santa Cruz Biotechnology,
diluted 1:200 and antibody against 3β-HSD, diluted 1:1000, kindly
provided as a gift form Prof. I. Mason (Edinburgh University), were
applied, respectively. A swine anti-rabbit biotinylated secondary
antibody (E0353, DAKO), diluted 1:500 in NSS was applied for 30
min at RT. Bound antibodies were visualized by incubating the
sections with ABC complex/HRP reagent (K0355, DAKO) for 30
min followed by color development with 3,3’-diaminobenzidine
tetrahydrochloride chromogene substrate (K3468, Liquid DAB+ kit,
DAKO), monitored microscopically. Sections were counterstained
with hematoxylin, dehydrated and coverslipped using Pertex mount-
ing medium (CellPath, Hemel Hempstead, UK) 
The specificity of immunostaining was checked for each antibody
using previously established procedures. For AR, this involved
preabsorption of the primary antibody with peptide immunogen
(Santa Cruz N-20 peptide sc-816P) and for 3β-HSD it involved
substitution of the primary antibody by normal swine (blocking)
serum. To allow comparative evaluation of the immunostaining,
tissue sections from control and treated animals were processed in
parallel on at least three occasions to ensure reproducibility of results;
on each occasion tissue sections from four to six animals in each
experimental group were immunostained and the intensity of immu-
nostaining was scored using an arbitrary scale ranging from negative
(-) through weakly positive (+) to intensely positive (+++).The scores
were used to compile table of results. 
In situ assay of apoptosis and quantification of apoptotic cells.
Paraffin cross sections (5 µm) of seminiferous tubules were mounted
on slides coated with 2% 3-aminopropyltriethoxysaline (Sigma),
deparaffinized and rehydrated. Apoptotic cells were detected in situ
by using terminal deoxynucleotidyl transferase (TdT)-mediated di-
goxigenin-11-dUTP nick end labelling (TUNEL) method that re-
sulted in a high degree of specificity and low background staining
[23]. For assessment of apoptosis, the percentage of seminiferous
tubules with apoptotic germ cells was determined by scoring 100
randomly selected tubules per section on four sections from different
animals at each time point after EDS administration [29]. Tubules
with even a single apoptotic cell were classified as containing apop-
totic cells. The number of apoptotic cells per tubule was assessed on
four sections. The apoptotic index was calculated by multiplying the
percentage of tubules containing apoptotic germ cells by the number
of apoptotic germ cells per tubule at each time point after EDS. The
data obtained were statistically analyzed by Student’s t-test. 
Hormone measurements. Serum levels of T were measured using
an enzyme-linked immunosorbent assay adapted from an earlier RIA
method of Sharpe and Bartlett [21] as described previously [1].
Serum T levels were measured after hexane-ether extraction of the
samples, using [3H] testosterone (Amersham International, UK) as
tracer. The concentrations of LH were determined by a RIA method
as described by Fraser and Sandow [11] using kits supplied by the
NIDDK (Bethesda, MD).
Results
As previously shown, EDS induced apoptosis of the
adult LC population in the testis resulting in total loss of
LCs within the first 24 hours [2]. The absence and
regeneration of LCs and their steroidogenic activity after
EDS administration was proved by immunostaining for
3β-HSD which is the key enzyme in testicular steroi-
dogenesis and a specific marker for visualization and
quantification of LCs [1]. In controls, intense immuno-
staining was observed in LC cytoplasm (Fig. 1A). A total
loss of LCs on day 3 and 7 after EDS was confirmed by
lack of 3β-HSD-immunopositive cells in the testis
(Fig.1B). First 3β-HSD-positive cells could be seen in
the testicular interstitium two weeks after EDS admin-
istration and the intensity of 3β-HSD immunostaining
was comparable to the control (Fig. 1C, Table 1). After
day 21, the number of 3β-HSD-immunoreactive cells
markedly increased (see Fig. 1. in Davidoff et al. [9]).
LC immunoreactivity for 3β-HSD correlated with
values of serum T levels measured by RIA. A severe
drop in T concentration below 0.1 ng/ml on day 7 after
EDS treatment was followed by gradual increase in T
levels after two and three weeks (Fig. 2). LH remained
elevated until the 3rd week after EDS administration. 
In control rats, AR was expressed in the nuclei of
LCs, PTCs and SCs but not in germ cells. Stage-specific
immunoexpression of AR was evident in SC nuclei with
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the most intense expression at stages VI-VIII of the
spermatogenic cycle and the lowest expression at stages
IX-XIV (Fig. 3A, Table 1), as reported previously [8,
25, 27]. Seven days after EDS administration there was
a total loss of AR immunoexpression from SCs, LCs and
PTCs, as indicated by lack of AR immunoreactivity in
the testis (Fig. 3B). Two weeks after treatment, AR
immunoexpression was recovered in these cell types but
there was no clear evidence for stage-specific expression
of AR in SCs (Table 1). Instead, uniform intensity of
Sertoli cell AR immunostaining in the tubules from all
the stages was observed (Fig. 3C). Three weeks after
EDS treatment, the uniform pattern of AR immunoex-
pression in SCs was still present and strong immunos-
taining was even found in SCs from Sertoli cell only
(SCO) tubules (Fig 3D). The normal stage-specific pat-
tern of AR immunoexpression was recovered 5 weeks
after EDS administration.
As recently reported [25], administration of 25 mg
testosterone ester at the time of EDS injection and 3 days
later prevented the loss of AR from the testis and main-
tained the normal stage-specific pattern in SC nuclei on
day 6 after EDS (Table 1).
Fig. 1. Immunoexpression of 3β-HSD in LCs of rat testis after EDS
treatment. × 400. A. Control testis; B. Testis from rat 7 days after
EDS administration. Note the absence of 3β-HSD immunostaining
in the interstitium; C. Testis from rat 14 days after EDS. Note the
appearance of new LCs (arrow) revealed by 3β-HSD immunoreac-
tivity with intensity comparable to the controls.
Table 1. Semiquantitative evaluation of the effect of EDS treatment
on immunoexpression of 3β-HSD in LC cytoplasm and AR in SC
nuclei
Experimental
groups
AR immunoexpression in SCs 3β-HSD
immuno-
expression 
in LCs
Stages
I-VI
Stages
VII-VIII
Stages
IX-XIV
Control + +++ + +++
EDS 6d - -/+* - -
EDS + 
testosterone 6d
+ +++ + -
EDS 7d - - - -
EDS 14d +++ +++ +++ +++
EDS 21d +++ +++ +++ +++
EDS 35d + +++ + +++
*-/+ indicates that a few cells are immunopositive, whereas most are
negative
Fig. 2. Levels of testosterone and LH at different time points after
EDS treatment. Data represent means±SD (n=5 for each experimen-
tal group). All the differences in values between treated and control
animals were significant (p<0.01). 
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First signs of seminiferous epithelium regression were
manifested by a marked increase in germ cell apoptotic
index on day 7 (144.14±21.40) in comparison with con-
trol rat testis (11.00±3.57). Afterwards the parameter
decreased but remained still significantly higher, com-
pared to control, on days 14 and 21 after EDS treatment
(29.27±4.90 and 29.20±13.32, respectively). Germ cell
apoptosis was followed by total loss of elongated sper-
matids from all the stages of the cycle by the 2nd week
after EDS (see Fig. 3C). First signs of spermatogenesis
recovery were manifested by the appearance of elong-
ated spermatids at late stages 3 weeks after EDS.
Fig. 3. Immunoexpression of AR in the rat testis after EDS treatment. × 400. A. Control testis. Note stage-specific staining in SC nuclei
(arrows) indicated by strong intensity in early I-VI (E) and VII-VIII stages and weak immunostaining in late IX -XIV (L) stages; B. Testis
from rat 7 days after EDS. Note the absence of AR immunoreactivity in the testis; C. Testis from rat 14 days after EDS. Note uniform intensity
of AR immunostaining in SC nuclei in tubules from early (E), VII-VIII and late (L) stages; D. Testis form rat 21 days after EDS. Strong AR
immunoexpression in SCs was found in Sertoli cell only (SCO) tubules.
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Discussion
The biological action of androgens in the testis is medi-
ated through the AR that functions as a transcriptional
factor to regulate initiation and maintenance of sperma-
togenesis [12]. The stage-specific pattern of AR immu-
noexpression in the Sertoli cells reported by us and other
authors [8, 25, 27] indicates that T exerts its supportive
effect on spermatogenesis acting specifically at stages
VII-VIII and that coincides with the maximal levels of
overall protein secretion by seminiferous tubules [22]. 
In the rat, T withdrawal is known to disrupt sperma-
togenesis [5, 15] and we therefore tested the effect of T
removal, using EDS, on the pattern of AR immunoex-
pression in the adult rat testis. The present study provides
new data about recovery of AR immunoexpression in
the testis in a long period after EDS treatment when new
LC population is developed in tandem with degeneration
and restoration of spermatogenesis. The lack of AR
immunostaining in all testicular cell types, found during
the first week, coincides with total loss of LCs proved
by lack of 3β-HSD-immunopositive cells and the lowest
plasma T concentrations. Comparative studies em-
ploying Western blotting and ligand-binding assay of
testicular AR revealed very low level of immunodetec-
table AR protein on day 5 after EDS administration in
contrast to normal binding ability of the receptor that
may point to a structural modification of the AR [7]. It
is possible that prolonged absence of androgens results
in an unstable conformation of the AR which is more
easily degraded within the cell [14, 27, 30]. 
The restoration of AR immunostaining in the testis
found 2 weeks after EDS treatment occurred in tandem
with the appearance of new generation of LCs as proved
by the presence of 3β-HSD immunoreactivity observed
in the present study and by detectable enzyme activity
[4]. As 3β-HSD is a marker for LC differentiation in
adult testis after EDS administration [26], the appear-
ance of 3β-HSD-positive cells occurred at the time when
progenitor LCs in the testis began to transform into
immature LCs [3] and that in turn led to gradual resto-
ration of T production. Immunoexpression of AR in SCs
was restored 2 weeks after EDS but instead of stage-spe-
cific pattern, we observed uniform staining present at all
the stages with the intensity identical to the maximal
staining at stage VII-VIII in the controls. This unifor-
mity of AR immunoexpression was maintained for a
long period of 3 weeks and normal, stage-specific AR
immunostaining appeared 5 weeks after EDS treatment
when T levels returned to the normal range [5]. The lack
of stage specificity of AR expression in SCs coincided
with the lack of an appropriate level of T support,
indicating the role of T-ligand in the proper functioning
(immunodetectability) of its own receptor [8]. There-
fore, maintenance of maximal intensity of AR imunoex-
pression at all the stages in EDS-treated rats could be
interpreted as a possible compensatory mechanism of an-
drogen signalling, needed for the regeneration of germ cell
population occurring in the same period after EDS treat-
ment. The great importance of adequate androgen signall-
ing via AR in the SCs for spermatogenesis was recently
demonstrated in transgenic mice with selective knockout
of AR in the SCs [10]. Germ cells in turn can control
production of several proteins by the SCs [6, 16]. Total loss
of elongated spermatids [3] coincides with the time of
absence of AR immunoexpression stage specificity in SCs.
However, the studies involving methoxyacetic acid
(MAA)-induced germ cell depletion do not indicate any
changes in stage-dependent staining of AR [8]. This, of
course does not eliminate the possibility that germ cells are
involved in the local control of AR expression, as different
mechanisms underlie germ cell depletion induced by
MAA (directly destroyed pachytene spermatocytes) and
EDS (hormonally induced germ cell apoptosis). 
In agreement with other studies, immunodetectability
of AR appeared to be controlled by the binding of T, since
AR immunostaining was markedly reduced in EDS-
treated rats and replacement of T at the time of EDS
administration or for 4 hours 6 days after EDS restored the
normal stage-specific pattern of AR staining in SCs [8, 27].
In addition, loss of AR in the male reproductive tract of
castrated rats was restored within 15 min of androgen
administration [19]. These results demonstrated that T
probably decreases the rate of AR degradation, controlling
the synthesis of its own receptor, as previously demon-
strated in prostate and other tissues [14, 18]. Studies on
EDS-treated rats supplemented with synthetic metabo-
lisable or nonmetabolisable androgens showed that stage-
dependent pattern of AR immunoexpression in SCs is not
due to androgen metabolism [28]. Although the pattern of
AR staining was very similar in EDS+T and control rats,
the quantitative levels of staining were somewhat lower in
the former animals [8]. This could be due to suppression
of FSH levels by T replacement [5, 23], if FSH is important
in maintaining normal AR expression. Recent studies
using EDS experimental model demonstrated a possible
non-cell cycle role of cyclin D2 in regulating stage-de-
pendent expression of the AR in SCs [25]. 
Comparative analysis of our data on the recovery of AR
in SCs in a long period after EDS administration (5 weeks)
and data from EDS plus T supplemented rats (1 week
duration; [27]) suggest that acute administration of high
amount of T is sufficient to restore quickly (within 3-6 days)
the stage-specific expression of AR in SCs, whereas gradual
increase in T production during long-term recovery after
EDS lasted 3 weeks. Different manner of the AR immunoex-
pression recovery we found in the SCs and LCs probably
reflects the different mechanisms via which both cell types
maintain their own levels of AR [20] . The specific changes
in AR after EDS treatment including loss and recovery of
AR in Sertoli cells paralleled with degenerative and regener-
ative events in Leydig and germ cell populations, confirm
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a close functional relationship between Sertoli, Leydig
and germ cells. 
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